These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19191681)

  • 21. Review article: advances in the management of patients with cirrhosis and portal hypertension-related renal dysfunction.
    Leithead JA; Hayes PC; Ferguson JW
    Aliment Pharmacol Ther; 2014 Apr; 39(7):699-711. PubMed ID: 24528130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular deterioration in cirrhosis: the big picture.
    Bosch J
    J Clin Gastroenterol; 2007; 41 Suppl 3():S247-53. PubMed ID: 17975472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamics in the isolated cirrhotic liver.
    Zipprich A
    J Clin Gastroenterol; 2007; 41 Suppl 3():S254-8. PubMed ID: 17975473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficacy of lisinopril and nebivolol therapy of portal hypertension and kidney dysfunction in patients with liver cirrhosis].
    Fedulenkova LV; Drozdov VN; Mikheeva OM; Petrakov AV
    Eksp Klin Gastroenterol; 2008; (5):37-41. PubMed ID: 19145915
    [No Abstract]   [Full Text] [Related]  

  • 25. [The role of intestinal microflora in the development of complications of hepatic cirrhosis-associated portal hypertension].
    Garbuzenko DV
    Klin Med (Mosk); 2007; 85(8):15-9. PubMed ID: 17926483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiology of portal hypertension in HCV-related cirrhosis. Putative role of assessment of portal pressure gradient in Peginterferon-treated patients.
    Ratti L; Pozzi M; Bosch J
    Dig Liver Dis; 2005 Nov; 37(11):886-93. PubMed ID: 16172033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation and treatment of portal hypertension].
    Brůha R; Petrtýl J
    Cas Lek Cesk; 2016; 155(2):22-6. PubMed ID: 27088788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional aspects on the pathophysiology of portal hypertension in cirrhosis.
    García-Pagán JC; Gracia-Sancho J; Bosch J
    J Hepatol; 2012 Aug; 57(2):458-61. PubMed ID: 22504334
    [No Abstract]   [Full Text] [Related]  

  • 29. [Aspects of pathogenetc pharmacotherapy for portal hypertension in liver cirrhosis].
    Garbuzenko DV
    Ter Arkh; 2016; 88(2):101-108. PubMed ID: 27135108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Focusing on the diagnosis and management of portal hypertension in cirrhosis].
    Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2017 Jun; 25(6):401. PubMed ID: 28763853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver surgery in cirrhosis and portal hypertension.
    Hackl C; Schlitt HJ; Renner P; Lang SA
    World J Gastroenterol; 2016 Mar; 22(9):2725-35. PubMed ID: 26973411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long term effects of propranolol on portal pressure in cirrhotic patients.
    Orban-Schiopu AM; Popescu CR
    Rom J Gastroenterol; 2003 Mar; 12(1):25-30. PubMed ID: 12673376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elastography methods for the non-invasive assessment of portal hypertension.
    Roccarina D; Rosselli M; Genesca J; Tsochatzis EA
    Expert Rev Gastroenterol Hepatol; 2018 Feb; 12(2):155-164. PubMed ID: 28856972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Portal hypertension and varices in patients with liver cirrhosis.
    Fullwood D
    Nurs Stand; 2012 Aug 1-7; 26(48):52-7; quiz 58. PubMed ID: 22916658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis.
    Møller S; Bendtsen F
    Liver Int; 2018 Apr; 38(4):570-580. PubMed ID: 28921803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.
    Abraldes JG; Tarantino I; Turnes J; Garcia-Pagan JC; Rodés J; Bosch J
    Hepatology; 2003 Apr; 37(4):902-8. PubMed ID: 12668985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Etiology and pathophysiology of portal hypertension.
    Reichen J
    Z Gastroenterol; 1988 Sep; 26 Suppl 2():3-7. PubMed ID: 3055716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noncirrhotic portal hypertension.
    Da BL; Koh C; Heller T
    Curr Opin Gastroenterol; 2018 May; 34(3):140-145. PubMed ID: 29465431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Late complications of liver cirrhosis - management of gastrointestinal bleeding in the presence of portal hypertension].
    Hejda V
    Vnitr Lek; 2016; 62(9 Suppl 2):10-17. PubMed ID: 27723988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful management of portopulmonary hypertension with beraprost.
    Kim EJ; Shin MS; Oh KY; Kim MG; Shin KC; Park YM; Kim BR; Chung WJ; Ahn TH; Choi IS; Shin EK
    Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1503-5. PubMed ID: 21389799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.